Clinical Trial Update: Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent [NA]

View source ↗

Summary

A completed clinical trial evaluated long-term nutritional support in patients with AIDS. It compared two lipid-emulsion formulations, Liposyn III 2% and Liposy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Liposyn II 20% (lipid emulsion)
• Liposyn III 2% (lipid emulsion)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | NA | Status: COMPLETED